Cited by 114Proteoglycans and glycosaminoglycans researchAxon Guidance and Neuronal SignalingNeurogenesis and neuroplasticity mechanisms

Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways

Miller, Brad, Sheppard, Allan M., Bicknese, Alma R., Pearlman, Alan L.·1995·Journal of Comparative Neurology

Abstract

The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.

Integrity signals

Registry

Crossref · 10.1002/cne.903550410

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neurocan expression increased between E14 and postnatal day 3 and then decreased during early-late adolescence and into adulthood.

    “Neurocan expression also increased between E14 and postnatal day (P) 3 and then decreased during early-late adolescence and into adulthood (Meyer-Puttlitz et al., 1996; Miller et al., 1996; Milev et al., 1998; Brückner et al., 2000).”

The citation lists haven’t been fetched yet

References 97 · Cited by 114

Authors
Miller, B., Sheppard, A. M., Bicknese, A. R., & Pearlman, A. L.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Pearlman, Alan L.
Venue
Journal of Comparative Neurology
Publisher
Wiley
Published
1995-05-15
Volume
355
Issue
4
Pages
615-628
ISSN
  • 0021-9967 (ISSN-L)
  • 1096-9861
OpenAlex
W2039296171
Cited by
114
References
97
Citations by year
2024: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
4.17
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Comparative Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5t32ns007027-18, 5r01ey000621-27)
  • National Eye Institute (EY07057, EY00621)
  • National Institute of Neurological Disorders and Stroke (NS07027)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
chondroitin sulfate proteoglycans, neurocan, thalamocortical connections, subplate, cortical development, axon guidance, chondroitin-6-sulfate, chondroitin 4-sulfate, phosphacan, syndecan-1, somatosensory cortex
MeSH terms
Afferent Pathways, Animals, Antibodies, Monoclonal, Axons, Cerebral Cortex, Chondroitin Lyases, Chondroitin Sulfates, Efferent Pathways, Female, Glycosaminoglycans, Immunohistochemistry, Nerve Tissue Proteins, Pregnancy, Chondroitin Sulfate Proteoglycans, Thalamus, Vibrissae, Lectins, C-Type, Rats, Neurocan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review